Cargando…

Lung cancer screening: who pays? who receives?—the Chinese perspective

The National Lung Screening Trial (NLST) revealed that low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20.0%. In China, LDCT is very cheap and easy to access. As a result, LDCT screening is not limited to “high-risk” population defined by the NLST trial. The results of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182701/
https://www.ncbi.nlm.nih.gov/pubmed/34164286
http://dx.doi.org/10.21037/tlcr.2020.03.16